Reprimand for possession of “ecstasy” and cocaine
The Statutory Committee has reprimanded a young New Zealand pharmacist
convicted of possessing “ecstasy” tablets and cocaine. The
chairman warned that pharmacists who used recreational drugs and supplied
them to others faced removal from the register.
At its meeting on 7 May 2003 the committee inquired into the case of
Kim Hilda Letford, of 7 Devereux Road, London SW11. Information had been
received that on 25 October 2002, at Bow Street magistrates’ court,
London, Miss Letford had pleaded guilty to, and been convicted of, two
counts of the possession of Class A Controlled Drugs, namely 20 tablets
of MDMA (methylenedioxymethamphetamine, “ecstasy”) and 0.516g
of cocaine, in contravention of the Misuse of Drugs Act 1971. Both offences
had taken place on 24 August 2002, at Heaven night club, London. Miss
Letford was fined a total of £450 and ordered to pay £50
costs.
The facts of the case were presented by Geoff Hudson, of Penningtons
(solicitors).
Miss Letford, who attended the inquiry, was represented by Scott Ewing,
of David Phillipson & Partners (solicitors).
Giving the committee’s decision, the chairman (Lord Fraser of Carmyllie,
QC), said that Miss Letford had been an extremely foolish and naive young
woman. Had she been convicted of intent to supply, which was included
in Section 4.1 of the Misuse of Drugs Act under which she had been charged
originally, there would have been no option but to remove her name from
the register. “Young pharmacists who use recreational drugs — or,
indeed, any pharmacist who use recreational drugs and supply them to
others — should be warned unequivocally that they face removal
from the register if convicted of that greater charge,” said Lord
Fraser. However, Miss Letford had been convicted of the lesser charge
of possession and the fines imposed indicated that the court had not
taken as serious a view as they sometimes did.
The nature of the conviction amounted to misconduct such as to render
Miss Letford unfit to be on the register, the chairman said. Any breach
of the Misuse of Drugs Act by pharmacists entrusted with public responsibilities
by Parliament was professionally wholly unacceptable. But, in her favour,
she had been frank with the police over her purchase of the drugs, her
profession, and what she had intended to do with the drugs. The committee
felt that she had learnt a salutary lesson.
She had provided good references; those, and her strong, influential family background
in New Zealand, were taken into account.
The committee directed that Miss Letford should be reprimanded and indicated
that the Pharmaceutical Society of New Zealand should be informed of the decision.
Back to Top
|